Arcadia Biosciences (RKDA) Misses Q4 EPS by 298c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($2.98). Revenue for the quarter came in at $1.22 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Goldman's GPIQ returns 20% in a year — and still pays a 9.47% yield at 0.29% fees
• Truist Securities Reiterates Buy Rating on Five9, Inc (FIVN)
• Trump discloses over $1.4 billion in crypto income in 2025 filing